Cervical Squamous Cell Carcinoma — Trials

Cervical Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

82 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 16
Recruiting: 9
Ph III recruiting: 1
Growth YoY: —
Industry share: 44%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 16.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02595879	Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer	active not recruiting	Phase 1	21	National Cancer Institute (NCI)NIH	1	Jul 31, 2026	clinicaltrials
NCT03983954	Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.	active not recruiting	Phase 1	120	NeoTX Therapeutics Ltd.INDUSTRY	2	Nov 28, 2025